JSM2026
Back to all people

Alexander Ooms

GSK
1 appearance in the program

Sessions & presentations

Platform/Basket Trials, safety Evaluation & Phase II Designs
Presentation: Rigorous Type I error control for randomized BOP2-TE designs under minimal assumptions
Contributed Papers · Thu, Aug 6 , 8:30 AM
Co-Author